Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03260361
Other study ID # RC31/16/8235
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 6, 2017
Est. completion date December 7, 2022

Study information

Verified date August 2023
Source University Hospital, Toulouse
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Relation between hypnosis and MEOPA on algodystrophy.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date December 7, 2022
Est. primary completion date November 7, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Regional Painful Syndrome Complex Exclusion Criteria: - deaf people

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Hypnosis, kinesitherapy, MEOPA
classical intervention
Usual practice
Usual practice with treatments and physio

Locations

Country Name City State
France Croix du Sud Quint Fonsegrives
France University Hospital of Toulouse Toulouse

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

References & Publications (1)

Oerlemans HM, Oostendorp RA, de Boo T, Perez RS, Goris RJ. Signs and symptoms in complex regional pain syndrome type I/reflex sympathetic dystrophy: judgment of the physician versus objective measurement. Clin J Pain. 1999 Sep;15(3):224-32. doi: 10.1097/00002508-199909000-00010. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain intensity measure using visual analogical ladder (EVA) pain intensity is determined by patient himself on a visual analogical ladder created by Huskisson 3 weeks
Secondary QDSA ( Saint Antoine Pain Questions) description of the type of pain 3 weeks
Secondary SF36 (Short Form (36) Health Survey) quality of life appreciation 3 weeks
Secondary HADs Hospital Anxiety and Depression Scale 3 weeks